Dr. Dziura has been the lead biostatistician for federally funded trials including several trials for the Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials, Phase II Trial of Teplizumab in Type 1 Diabetes, and the Bright Bodies Lifestyle Intervention Trial for Weight Management in Children. He’s currently the Principle Investigator for the Data Coordinating Center of the RUPP trial investigating the use of Guanfacine in PDD.